-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Raises Price Target to $155

Benzinga·12/15/2025 18:18:59
Listen to the news
Wells Fargo analyst Brandon Couillard maintains GeneDx Holdings (NASDAQ:WGS) with a Equal-Weight and raises the price target from $140 to $155.